Schedule a Free Evaluation: 919-354-3775 contact@extivita.org
  • Facebook
  • Twitter
  • Instagram
  • RSS
  • Facebook
  • Twitter
  • Instagram
  • RSS
  • Patient Portal
  • Register
  • Contact
Extivita - Hyperbaric Oxygen Therapy - Durham, NC
  • Home
  • Conditions We Treat
  • Therapies
    • Hyperbaric Oxygen
    • IV Therapy
    • Neurofeedback
    • Supplements
    • Longevity Challenge
  • Testimonials
  • About
    • News
    • Research
    • Extivita RTP Team
Select Page

Seizures during hyperbaric oxygen therapy: retrospective analysis of 62,614 treatment sessions.

by Extivita | Mar 23, 2016 | Traumatic Brain Injury (TBI)

Abstract: Hyperbaric oxygen (HBO₂) therapy is considered to be a generally safe therapy. However, data regarding seizure incidence during HBO₂ therapy as a clinical presentation of central nervous system- (CNS) related oxygen toxicity are conflicting (ranging from...

Seizures during hyperbaric oxygen therapy: retrospective analysis of 62,614 treatment sessions.

by Extivita | Mar 23, 2016 | Stroke

Abstract: Hyperbaric oxygen (HBO₂) therapy is considered to be a generally safe therapy. However, data regarding seizure incidence during HBO₂ therapy as a clinical presentation of central nervous system- (CNS) related oxygen toxicity are conflicting (ranging from...

MicroRNA-148b is a potential prognostic biomarker and predictor of response to radiotherapy in non-small-cell lung cancer.

by Extivita | Feb 22, 2016 | Cancer

Abstract: miR-148b has been found to be aberrantly expressed in various tumor types. It has recently been reported to be involved in regulating radioresistance in non-small cell lung cancer (NSCLC) cells. However, its expression level and association with...

Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.

by Extivita | Jan 22, 2015 | Carcinoma

Abstract: Long non-coding RNAs (lncRNAs) play widespread roles in gene regulation and cellular processes. However, the functional roles of lncRNAs in hepatocellular carcinoma (HCC) are not yet well elucidated. The aim of the present study was to measure the levels of...

Retinal artery occlusion: visual outcome after treatment with hyperbaric oxygen.

by Extivita | Apr 4, 2011 | Central Retinal Artery Occlusion (CRAO)

Abstract: We describe a case series of 11 patients with retinal artery occlusion treated with hyperbaric oxygen therapy (HBOT) at Intermountain Dixie Regional Medical Center between 2005 and 2009. We then combined data from our case series with data from two other...
« Older Entries

Search News

 

Archives

 

Contact Us

     

     

     

     

    Professional Memberships

    HBOT Member Logo
    • About Extivita
    • Extivita RTP Team
    • Patient Portal
    • Register
    • Contact
    • Policies
    • Facebook
    • Twitter
    • Instagram
    • RSS
    © 2015-2020 Extivita, LLC
    Hyperbaric Oxygen Therapy (HBOT) Clinic located in Research Triangle Park, North Carolina (RTP, Raleigh, Durham, Chapel Hill).